Introduction. Coronavirus 2019 disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has spread to more than 200 countries worldwide. We aimed to present acute pancreatitis (AP) cases caused by SARS-CoV-2 viral infection. Methods. The study was conducted retrospectively between April 2020 and June 2020 in Necmettin Erbakan University Meram, Medical Faculty Hospital, and 150 hospitalized patients diagnosed with COVID-19 were included. The degree of acute pancreatitis was determined according to the Atlanta classification. Organ failures of the patients were evaluated in terms of respiratory, cardiovascular, and nephrology according to the modified Marshall scoring (MMS) system, and CTSI (Balthazar score) and Imrie score were determined. was considered organ failure. Results. A total of 29 patients were diagnosed with acute pancreatitis. All 29 patients with pancreatitis had respiratory failure during hospitalization. After the diagnosis of pancreatitis, there was no change in respiratory failure. According to the Atlanta classification, 19 patients had mild AP and 10 patients had moderate AP. Patients with acute pancreatitis were scored according to the CTSI (Balthazar score), and there were no patients with ≥6 severe pancreatitis. The CTSI score of 4 patients was 3. In addition, the Imrie score of the patients was determined and 8 patients with were identified. Conclusion. The rate of pancreatic damage in SARS-CoV-2 infection was found to be 19% () in our study. In our study, we highlight acute pancreatitis as a complication associated with COVID-19 and the importance of pancreatic evaluation in patients with COVID-19 and abdominal pain is demonstrated.

中文翻译：

---

SARS-CoV-2病毒感染引起的急性胰腺炎的临床评价

引言。由严重急性呼吸系统综合症冠状病毒2（SARS-CoV-2）引起的冠状病毒2019病（COVID-19）已蔓延到全球200多个国家。我们旨在介绍由SARS-CoV-2病毒感染引起的急性胰腺炎（AP）病例。方法。这项研究是在2020年4月至2020年6月期间在内科米丁·厄尔巴坎大学梅拉姆分校医学系医院进行的，其中包括150名被诊断为COVID-19的住院患者。根据亚特兰大分类确定急性胰腺炎的程度。根据改良的Marshall评分（MMS）系统对患者的器官衰竭进行了呼吸，心血管和肾病学评估，并确定了CTSI（Balthazar评分）和Imrie评分。被认为是器官衰竭。结果。共有29例患者被诊断为急性胰腺炎。所有29例胰腺炎患者在住院期间均出现呼吸衰竭。诊断为胰腺炎后，呼吸衰竭无变化。根据亚特兰大分类，有19例为轻度AP，10例为中度AP。急性胰腺炎患者根据CTSI（Balthazar评分）进行评分，没有6例以上的重度胰腺炎患者。4例患者的CTSI评分为3。此外，确定了患者的Imrie评分，并确定了8例患者的CTSI评分。被确定。结论。发现SARS-CoV-2感染的胰腺损害率为19％（）在我们的研究中。在我们的研究中，我们强调了急性胰腺炎是与COVID-19相关的并发症，并证明了胰腺评估在COVID-19和腹痛患者中的重要性。